Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Craig Horbinski

Showing results (31-40 of 209) with videos related to

Pageof 21
Sort By:
Free Radical Biology & Medicine|July 3, 2007
6-Hydroxydopamine induces mitochondrial ERK activationScott M Kulich, Craig Horbinski, Manisha Patel, et al.
Neuro-Oncology|December 18, 2024
NCCN CNS Tumor Guidelines Update for 2024Louis Burt Nabors, Jona Hattangadi-Gluth, Craig Horbinski, et al.
Advances in Oncology|June 25, 2026
Treatment of Isocitrate Dehydrogenase-Mutant GliomasSofia Chernet, Hannah Kim, Ankush Bhatia, et al.
Journal of Neuropathology and Experimental Neurology|December 5, 2021
Next-Generation Sequencing of a Glioblastoma with True Epithelial DifferentiationCollin J Larkin, Lawrence J Jennings, Amy B Heimberger, et al.
The American Journal of Pathology|August 16, 2011
EGFR expression stratifies oligodendroglioma behaviorCraig Horbinski, Jonathan Hobbs, Kathleen Cieply, et al.
Neuro-Oncology Advances|February 7, 2022
Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutationMichael Drumm, Jessica W Templer, Matthew Tate, et al.
Nature Reviews. Rheumatology|June 13, 2012
Implications of glucocorticoid therapy in idiopathic inflammatory myopathiesBeatriz Y Hanaoka, Charlotte A Peterson, Craig Horbinski, et al.
Case Reports in Clinical Pathology|January 15, 2024
Refractory anaplastic astrocytoma responsive to PCV in combination with bevacizumabArun Swaminathan, Donita D Lightner, Thomas Pittman, et al.
The Neurologist|May 27, 2024
Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma): A Unique Treatment Approach for a Rare Central Nervous System TumorLauren Singer, Jorie Singer, Craig Horbinski, et al.
Acta Neuropathologica|August 20, 2014
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cellsYinxing Liu, Misty R Gilbert, Natasha Kyprianou, et al.
Pageof 21

Showing results (31-40 of 209) with videos related to

Sort By:
Pageof 21
Free Radical Biology & Medicine|July 3, 2007
6-Hydroxydopamine induces mitochondrial ERK activationScott M Kulich, Craig Horbinski, Manisha Patel, et al.
Neuro-Oncology|December 18, 2024
NCCN CNS Tumor Guidelines Update for 2024Louis Burt Nabors, Jona Hattangadi-Gluth, Craig Horbinski, et al.
Advances in Oncology|June 25, 2026
Treatment of Isocitrate Dehydrogenase-Mutant GliomasSofia Chernet, Hannah Kim, Ankush Bhatia, et al.
Journal of Neuropathology and Experimental Neurology|December 5, 2021
Next-Generation Sequencing of a Glioblastoma with True Epithelial DifferentiationCollin J Larkin, Lawrence J Jennings, Amy B Heimberger, et al.
The American Journal of Pathology|August 16, 2011
EGFR expression stratifies oligodendroglioma behaviorCraig Horbinski, Jonathan Hobbs, Kathleen Cieply, et al.
Neuro-Oncology Advances|February 7, 2022
Markedly prolonged disease course, with breakthrough seizures, in a glioma with an isolated IDH1 mutationMichael Drumm, Jessica W Templer, Matthew Tate, et al.
Nature Reviews. Rheumatology|June 13, 2012
Implications of glucocorticoid therapy in idiopathic inflammatory myopathiesBeatriz Y Hanaoka, Charlotte A Peterson, Craig Horbinski, et al.
Case Reports in Clinical Pathology|January 15, 2024
Refractory anaplastic astrocytoma responsive to PCV in combination with bevacizumabArun Swaminathan, Donita D Lightner, Thomas Pittman, et al.
The Neurologist|May 27, 2024
Immunotherapy for Solitary Fibrous Tumor (Hemangiopericytoma): A Unique Treatment Approach for a Rare Central Nervous System TumorLauren Singer, Jorie Singer, Craig Horbinski, et al.
Acta Neuropathologica|August 20, 2014
The tumor suppressor prostate apoptosis response-4 (Par-4) is regulated by mutant IDH1 and kills glioma stem cellsYinxing Liu, Misty R Gilbert, Natasha Kyprianou, et al.
Pageof 21